СВЕРХРАННИЕ БЕЛКИ ЦИТОМЕГАЛОВИРУСА УЧАСТВУЮТ В УСТАНОВЛЕНИИ РЕЗИСТЕНТНОСТИ К ПРОТИВООПУХОЛЕВОМУ АНТИБИОТИКУ ДОКСОРУБИЦИНУ ИНФИЦИРОВАННЫХ КЛЕТОК ЛЕЙКЕМИИ ТНР-1

1. Söderberg-Nauclér C., Johnsen J.I. Cytomegalovirus in human brain tumors: Role in pathogenesis and potential treatment options // World J Exp Med. 2015; 5(1): 1-10

2. Tsuchiya S., Yamabe M., Yamaguchi Y., et al. Establishment and characterization of a human acute monocytic leukemia cell line (THP 1) // Int. J. Cancer 1980; 26: 171-176

3. Yang F., Teves S.S., Kemp C.J., Henikoff S. Doxorubicin, DNA torsion, and chromatin dynamics // Biochim Biophys Acta 2014; 1845: 84-89

4. Tolosa L, Donato MT, Gómez-Lechón MJ. General Cytotoxicity Assessment by Means of the MTT Assay // Methods Mol Biol. 2015; 1250: 333-48.

5. Cheng S., Caviness K., Buehler J., et al. Transcriptome-wide characterization of human cytomegalovirus in natural infection and experimental latency // Proc Natl Acad Sci USA. 2017; 114(49): p. Е10586 Е10595.

6. Arcangeletti M., Vasile S., Rodighiero I, et al. Human cytomegalovirus reactivation from latency: validation of a "switch" model in vitro // Virol J. 2016; 13(1): 179.

7. Mocarski E., Shenk T., Griffiths P.D., Pass F.R. Cytomegaloviruses. Knipe D.M., Howley P.M., editors. Fields Virology. 6th ed. Volume 2. USA: Lippincott Williams and Wilkins, Philadelphia; 2013.

8. Spector D.H. Human cytomegalovirus riding the cell cycle // Med Microbiol Immunol. 2015; 204(3): 409-419.